Choroid plexus tumors differ from metastatic carcinomas by expression of the excitatory amino acid transporter-1

Human Pathology

Volumn 37, Issue 7, 2006, Pages 854-860

  Beschorner, Rudi ^a   Schittenhelm, Jens ^a   Schimmel, Heiko ^b   Iglesias Rozas, José R ^c   Herberts, Tina ^a   Schlaszus, Holger ^a   Meyermann, Richard ^a   Wehrmann, Manfred ^b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c Katharinenhospital   (Germany)

Author keywords

Carcinoma; Choroid plexus tumors; Differential diagnosis; Excitatory amino acid transporter 1; Metastasis

Indexed keywords

BIOLOGICAL MARKER; EXCITATORY AMINO ACID TRANSPORTER; EXCITATORY AMINO ACID TRANSPORTER 1; PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CARCINOMA; CELL COUNT; CHILD; CHOROID PLEXUS PAPILLOMA; CHOROID PLEXUS TUMOR; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; GLIA; GROUPS BY AGE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFANT; MALE; MEMBRANE; METASTASIS; NEWBORN; ORGAN; PAPILLARY CARCINOMA; PREDICTOR VARIABLE; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TISSUE DIFFERENTIATION; TUMOR CELL;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGE FACTORS; AGED; CARCINOMA; CHILD; CHILD, PRESCHOOL; CHOROID PLEXUS NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; EXCITATORY AMINO ACID TRANSPORTER 1; FEMALE; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NEUROECTODERMAL TUMORS; SEX FACTORS;

EID: 33745280562     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2006.02.008     Document Type: Article

References (29)

1. Aguzzi A., Brandner S., and Paulus W. Choroid plexus tumours. In: Kleihues P., and Cavenee W.K. (Eds). Pathology and genetics of tumours of the nervous system (2000), IARCPress, Lyon 83-86
2. Gyure K.A., and Morrison A.L. Cytokeratin 7 and 20 expression in choroid plexus tumors: utility in differentiating these neoplasms from metastatic carcinomas. Mod Pathol 13 (2000) 638-643
3. Janisch W., and Staneczek W. Epidemiologie der Tumoren des Zentralnervensystems-Einfluss der Obduktionsquote auf die Inzidenzrate (Epidemiology of tumors of the central nervous system-influence of the autopsy rate on the incidence rate). Arch Geschwulstforsch 58 (1988) 51-55
4. Percy A.K., Elveback L.R., Okazaki H., and Kurland L.T. Neoplasms of the central nervous system. Epidemiologic considerations. Neurology 22 (1972) 40-48
5. Walker A.E., Robins M., and Weinfeld F.D. Epidemiology of brain tumors: the national survey of intracranial neoplasms. Neurology 35 (1985) 219-226
6. Andreini L., Doglioni C., and Giangaspero F. Tubular adenoma of choroid plexus: a case report. Clin Neuropathol 10 (1991) 137-140
7. Davis R.L., and Fox G.E. Acinar choroid plexus adenoma. Case report. J Neurosurg 33 (1970) 587-590
8. Rickert C.H., and Paulus W. Tumors of the choroid plexus. Microsc Res Tech 52 (2001) 104-111
9. Paulus W., and Janisch W. Clinicopathologic correlations in epithelial choroid plexus neoplasms: a study of 52 cases. Acta Neuropathol (Berl) 80 (1990) 635-641
10. Lantos P.L., Louis D.N., Rosenblum M.K., and Kleihues P. Tumours of the choroid plexus. In: Graham D.I., and Lantos P.L. (Eds). Greenfield's neuropathology. 7th ed (2002), Arnold, London 834-839
11. McLendon R.E., and Enterline D.S. Tumors of specialized tissue of central neuroepithelial origin. In: Bigner D.D., McLendon R.E., and Bruner J.M. (Eds). Russel & Rubinsteins's pathology of tumors of the nervous system. 6 ed (1998), Arnold, London 3-65
12. Wadiche J.I., Arriza J.L., Amara S.G., and Kavanaugh M.P. Kinetics of a human glutamate transporter. Neuron 14 (1995) 1019-1027
13. Kanner B.I., and Sharon I. Active transport of l-glutamate by membrane vesicles isolated from rat brain. Biochemistry 17 (1978) 3949-3953
14. Lopez-Bayghen E., and Ortega A. Glutamate-dependent transcriptional regulation of GLAST: role of PKC. J Neurochem 91 (2004) 200-209
15. Voutsinos-Porche B., Knott G., Tanaka K., et al. Glial glutamate transporters and maturation of the mouse somatosensory cortex. Cereb Cortex 13 (2003) 1110-1121
16. Duan S., Anderson C.M., Stein B.A., and Swanson R.A. Glutamate induces rapid upregulation of astrocyte glutamate transport and cell-surface expression of GLAST. J Neurosci 19 (1999) 10193-10200
17. Gottschalk J., Jautzke G., Paulus W., Goebel S., and Cervos-Navarro J. The use of immunomorphology to differentiate choroid plexus tumors from metastatic carcinomas. Cancer 72 (1993) 1343-1349
18. Herbert J., Cavallaro T., and Dwork A.J. A marker for primary choroid plexus neoplasms. Am J Pathol 136 (1990) 1317-1325
19. Matsushima T., Inoue T., Takeshita I., et al. Choroid plexus papillomas: an immunohistochemical study with particular reference to the coexpression of prealbumin. Neurosurgery 23 (1988) 384-389
20. Hayashi Y., Wang W., Ninomiya T., et al. Liver enriched transcription factors and differentiation of hepatocellular carcinoma. Mol Pathol 52 (1999) 19-24
21. Varga Z., and Vajtai I. Prognosztikus markerek a plexus chorioideus daganatainak korszovettani diagnosztikajaban (Prognostic markers in the histopathological diagnosis of tumors of the choroid plexus). Orv Hetil 139 (1998) 761-765
22. Ang L.C., Debowski T., and Michalski R. Immunolocalization of prealbumin (transthyretin) in renal cell carcinoma. Histopathology 18 (1991) 565-568
23. Nesland J.M., Ottestad L., Heikilla R., et al. C-erbB-2 protein and neuroendocrine expression in breast carcinomas. Anticancer Res 11 (1991) 161-167
24. Herrera G.A., Turbat-Herrera E.A., and Lott R.L. S-100 protein expression by primary and metastatic adenocarcinomas. Am J Clin Pathol 89 (1988) 168-176
25. Ito Y., Yoshida H., Tomoda C., et al. Expression of S100A2 and S100A6 in thyroid carcinomas. Histopathology 46 (2005) 569-575
26. Gokden N., Nappi O., Swanson P.E., et al. Renal cell carcinoma with rhabdoid features. Am J Surg Pathol 24 (2000) 1329-1338
27. Budk H. Non-glial specificities of immunocytochemistry for the glial fibrillary acidic protein (GFAP). Triple expression of GFAP, vimentin and cytokeratins in papillary meningioma and metastasizing renal carcinoma. Acta Neuropathol (Berl) 72 (1986) 43-54
28. Perry A., Parisi J.E., and Kurtin P.J. Metastatic adenocarcinoma to the brain: an immunohistochemical approach. Hum Pathol 28 (1997) 938-943
29. Xiang J., Ennis S.R., Abdelkarim G.E., et al. Glutamine transport at the blood-brain and blood-cerebrospinal fluid barriers. Neurochem Int 43 (2003) 279-288